Search details
1.
The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity.
Nat Immunol
; 20(3): 337-349, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30778251
2.
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche.
Cell
; 166(5): 1117-1131.e14, 2016 Aug 25.
Article
in English
| MEDLINE | ID: mdl-27565342
3.
BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers.
Nat Immunol
; 17(7): 851-860, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27158840
4.
An engineered IL-2 partial agonist promotes CD8+ T cell stemness.
Nature
; 597(7877): 544-548, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34526724
5.
Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells.
Nat Immunol
; 12(12): 1230-7, 2011 Nov 06.
Article
in English
| MEDLINE | ID: mdl-22057288
6.
Ionic immune suppression within the tumour microenvironment limits T cell effector function.
Nature
; 537(7621): 539-543, 2016 09 22.
Article
in English
| MEDLINE | ID: mdl-27626381
7.
Th17 cells are long lived and retain a stem cell-like molecular signature.
Immunity
; 35(6): 972-85, 2011 Dec 23.
Article
in English
| MEDLINE | ID: mdl-22177921
8.
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.
Cancer Immunol Immunother
; 68(11): 1805-1817, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31628526
9.
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Nature
; 498(7455): 506-10, 2013 Jun 27.
Article
in English
| MEDLINE | ID: mdl-23728300
10.
Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.
J Immunol
; 197(2): 644-54, 2016 07 15.
Article
in English
| MEDLINE | ID: mdl-27271569
11.
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines.
Proc Natl Acad Sci U S A
; 112(2): 476-81, 2015 Jan 13.
Article
in English
| MEDLINE | ID: mdl-25548153
12.
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma.
Mol Ther
; 23(8): 1380-1390, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25939491
13.
T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy.
Proc Natl Acad Sci U S A
; 110(17): 6973-8, 2013 Apr 23.
Article
in English
| MEDLINE | ID: mdl-23576742
14.
Therapeutic cancer vaccines: are we there yet?
Immunol Rev
; 239(1): 27-44, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-21198663
15.
Collapse of the tumor stroma is triggered by IL-12 induction of Fas.
Mol Ther
; 21(7): 1369-77, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23568260
16.
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes.
J Immunother Cancer
; 12(5)2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38816232
17.
Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.
Cancer Immunol Immunother
; 62(4): 727-36, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23207483
18.
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.
Blood
; 117(3): 808-14, 2011 Jan 20.
Article
in English
| MEDLINE | ID: mdl-20971955
19.
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.
J Immunol
; 186(2): 685-96, 2011 Jan 15.
Article
in English
| MEDLINE | ID: mdl-21149604
20.
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells.
Cancer Res Commun
; 3(5): 917-932, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37377887